Posse Herrera Ruiz advised Alliance Vascular Deviles LLC, through Wagenknecht IP Law Group, the patent prosecution of a medical infusion device commonly used in hospitals and medical care facilities to administer chemotherapy, provide intravenous fluids and transfuse blood.
Typically, these devices are used to administer treatments through a medical port implanted under the skin and connected to a catheter.
Accessing the medical port involves inserting the non-coring needle into a septum at the top of the port.
The septum is capable of resealing after removal of the non-coring needle, thereby allowing multiple uses of a same port.
ALPINA
In regulatory matters relating to their products, including sanitary registrations for food products not only in Colombia but in other LATAM jurisdictions.
This year we have also advised them regarding the new labelling regulations in Colombia and their applicability to their products as well as from when they were obligated to comply with the regulations.
SOLLA
We continue to advise Solla in all the registration processes regarding their animal food products in Latam.
CARDIX THERAPEUTICS
We have advised Cardix Therapeutics in a patent request for a pharmaceutical composition for treating or ameliorating bradycardia or cardiovascular disease.
One form of cardiac arrhythmia is bradycardia, a slow heart rate condition, which can cause fainting, dizziness, malaise, general weakness, excessive fatigue, chest pain, or failing memory. With no approved drug therapy available for the effective treatment of chronic bradycardia, a cardiac pacemaker must often be installed into a patient to sustain his/her life.
BOZICEVIC, FIELD & FRANCIS LLP
Posse Herrera Ruiz advised Regeneron Pharmaceutical, through Bozicevic, Field & Francis, in the patent prosecution of a present invention provides isolated monoclonal antibodies and antigen-binding fragments thereof that specifically bind to tropomyosin-receptor-kinase B (TrkB).
In its broadest aspect, the invention provides anti -TrkB agonist antibodies, which activate TrkB and promote neuronal survival.
Meet the team 